Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
68.48
-3.05 (-4.26%)
At close: Dec 5, 2025, 4:00 PM EST
68.10
-0.38 (-0.55%)
After-hours: Dec 5, 2025, 6:38 PM EST

Mirum Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
3,5191,9851,376719486511
Upgrade
Market Cap Growth
77.00%44.25%91.51%47.79%-4.80%-7.70%
Upgrade
Enterprise Value
3,4632,0181,378535299380
Upgrade
Last Close Price
68.4841.3529.5219.5015.9517.46
Upgrade
PS Ratio
7.165.897.389.3225.41-
Upgrade
PB Ratio
12.038.805.535.064.042.97
Upgrade
P/TBV Ratio
58.51--8.654.792.97
Upgrade
P/FCF Ratio
79.41212.71----
Upgrade
P/OCF Ratio
78.75192.25----
Upgrade
EV/Sales Ratio
7.345.997.396.9515.62-
Upgrade
EV/FCF Ratio
78.13216.27----
Upgrade
Debt / Equity Ratio
1.091.411.240.020.020.02
Upgrade
Debt / FCF Ratio
7.1934.05----
Upgrade
Asset Turnover
0.650.510.370.240.07-
Upgrade
Inventory Turnover
4.163.653.383.50--
Upgrade
Quick Ratio
3.012.834.072.723.7612.56
Upgrade
Current Ratio
3.313.104.452.943.9112.80
Upgrade
Return on Equity (ROE)
-15.81%-37.08%-83.65%-103.46%-57.47%-68.29%
Upgrade
Return on Assets (ROA)
-3.60%-8.31%-13.65%-25.33%-40.48%-33.64%
Upgrade
Return on Capital (ROIC)
-4.50%-9.95%-19.46%-61.42%-72.69%-42.14%
Upgrade
Return on Capital Employed (ROCE)
-6.70%-16.10%-19.50%-45.50%-68.80%-46.90%
Upgrade
Earnings Yield
-1.18%-4.43%-11.88%-18.88%-17.27%-20.22%
Upgrade
FCF Yield
1.26%0.47%-5.16%-16.76%-27.31%-17.48%
Upgrade
Buyback Yield / Dilution
-4.69%-16.23%-20.31%-12.07%-20.08%-119.84%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.